Shares of Snap Inc. (NYSE:SNAP) are picking up steam again. Snapchat's parent company has seen its stock move nicely higher for four consecutive trading days, surging 17% in the process. Snap is also trading higher on Tuesday, so the winning streak may not be over just yet.
Snap stock has been on fire since noted worrywart Citron Research issued a rare buy recommendation last week. Citron -- best known for skewering high-flying stocks with questionable business models -- feels that the dot-com laggard is oversold at this point. Citron argues that the heavily shorted stock already has the negative catalysts and news flow priced into the shares, and has set a target price of $17 on the stock. That's plenty of upside for a stock waffling about in the pre-teens at the time of the report.
Image source: Snap, Inc.
Top 5 Low Price Stocks To Watch For 2019: Asbury Automotive Group Inc(ABG)
Advisors' Opinion:- [By Max Byerly]
These are some of the news stories that may have effected Accern Sentiment Analysis’s scoring:
Get Asbury Automotive Group alerts: Should Value Investors Pick Asbury Automotive (ABG) Stock? (finance.yahoo.com) Asbury Automotive Group (ABG) and Rush Enterprises (RUSHA) Financial Review (americanbankingnews.com) Asbury Automotive Group, Inc. (ABG) Given Consensus Recommendation of “Hold” by Brokerages (americanbankingnews.com) Head-To-Head Review: Asbury Automotive Group (ABG) versus Murphy USA (MUSA) (americanbankingnews.com) Comparing Asbury Automotive Group (ABG) and TravelCenters of America (TA) (americanbankingnews.com)A number of equities research analysts have recently weighed in on the stock. Buckingham Research raised their price objective on shares of Asbury Automotive Group from $75.00 to $77.00 and gave the company a “buy” rating in a report on Wednesday, April 25th. Zacks Investment Research upgraded shares of Asbury Automotive Group from a “hold” rating to a “buy” rating and set a $78.00 price objective on the stock in a report on Wednesday, May 16th. ValuEngine lowered shares of Asbury Automotive Group from a “buy” rating to a “hold” rating in a report on Tuesday, May 22nd. Finally, Morgan Stanley raised their price objective on shares of Asbury Automotive Group from $53.00 to $63.00 and gave the company an “underweight” rating in a report on Wednesday, March 14th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company. Asbury Automotive Group currently has a consensus rating of “Hold” and a consensus price target of $67.33.
- [By Max Byerly]
Get a free copy of the Zacks research report on Asbury Automotive Group (ABG)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Asbury Automotive Group (NYSE:ABG) will post its quarterly earnings results before the market opens on Wednesday, February 6th. Analysts expect Asbury Automotive Group to post earnings of $2.06 per share for the quarter.
- [By Ethan Ryder]
Arizona State Retirement System lifted its position in shares of Asbury Automotive Group, Inc. (NYSE:ABG) by 2.2% in the fourth quarter, Holdings Channel reports. The fund owned 30,187 shares of the company’s stock after buying an additional 662 shares during the period. Arizona State Retirement System’s holdings in Asbury Automotive Group were worth $2,012,000 at the end of the most recent quarter.
- [By Jon C. Ogg]
Asbury Automotive Group Inc. (NYSE: ABG) was raised to Equal Weight from Underweight at Morgan Stanley, which also raised the price target to $71 from $63. Asbury shares previously closed at $72.40, but they were down 1.1% at $71.60 on Tuesday morning. The 52-week trading range is $49.10 to $76.50, and the previous consensus analyst target price was $75.86.
Top 5 Low Price Stocks To Watch For 2019: Nuveen Pennsylvania Investment Quality Municipal Fund, Inc.(NQP)
Advisors' Opinion:- [By Garrett Baldwin]
And we've tapped into a secret way to get growth and income thanks to legalized gambling by owning the Nuveen Pennsylvania Quality (NYSE: NQP) closed-end fund.
Top 5 Low Price Stocks To Watch For 2019: VOC Energy Trust(VOC)
Advisors' Opinion:- [By Shane Hupp]
Deutsche Bank AG reduced its position in VOC Energy Trust (NYSE:VOC) by 64.5% in the 4th quarter, Holdings Channel reports. The firm owned 19,000 shares of the oil and gas producer’s stock after selling 34,500 shares during the period. Deutsche Bank AG’s holdings in VOC Energy Trust were worth $112,000 as of its most recent filing with the SEC.
Top 5 Low Price Stocks To Watch For 2019: Arena Pharmaceuticals, Inc.(ARNA)
Advisors' Opinion:- [By Shane Hupp]
Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) have received a consensus rating of “Buy” from the eleven analysts that are covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $58.88.
- [By Stephan Byrd]
Partner Fund Management L.P. purchased a new position in shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) in the 2nd quarter, HoldingsChannel reports. The fund purchased 1,196,891 shares of the biopharmaceutical company’s stock, valued at approximately $52,184,000.
- [By Logan Wallace]
State Board of Administration of Florida Retirement System increased its position in shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) by 17.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,633 shares of the biopharmaceutical company’s stock after buying an additional 3,590 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in Arena Pharmaceuticals were worth $1,030,000 at the end of the most recent quarter.
- [By Max Byerly]
Macquarie Group Ltd. lifted its position in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) by 4.5% in the 2nd quarter, HoldingsChannel reports. The fund owned 490,000 shares of the biopharmaceutical company’s stock after buying an additional 20,900 shares during the period. Macquarie Group Ltd.’s holdings in Arena Pharmaceuticals were worth $21,364,000 as of its most recent SEC filing.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Arena Pharmaceuticals (ARNA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By ]
Arena Pharmaceuticals (ARNA) : "I like specialty pharma. This is a good one, too."
Dominion Energy (D) : "You have to buy it. It's time to think long-term."
Top 5 Low Price Stocks To Watch For 2019: Cross Timbers Royalty Trust(CRT)
Advisors' Opinion:- [By Ethan Ryder]
Cross Timbers Royalty Trust (NYSE:CRT) announced a dividend on Tuesday, August 21st, NASDAQ reports. Stockholders of record on Friday, August 31st will be paid a dividend of 0.108 per share by the oil and gas company on Monday, September 17th. The ex-dividend date of this dividend is Thursday, August 30th.
- [By Ethan Ryder]
News stories about Cross Timbers Royalty Trust (NYSE:CRT) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cross Timbers Royalty Trust earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned headlines about the oil and gas company an impact score of 47.0297657024049 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
No comments:
Post a Comment